BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
Single Test on BD MAX System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample
FRANKLIN LAKES, N.J., Aug. 1, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leadi... Diagnostics, FDA BD , Respiratory Viral Panel, SARS-CoV-2, Respiratory Syncytial Virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: COVID-19 | Infectious Diseases | Influenza | Marketing | Pharmaceuticals | Respiratory Medicine | SARS